<DOC>
	<DOCNO>NCT00944268</DOCNO>
	<brief_summary>To evaluate efficacy tolerability combination use Passiflora incarnata L , Crataegus oxyacantha Salix alba L mild moderate anxiety . Clinical study phase III , multicenter , prospective , open . Patients include sufficient quantity achieve minimum number 124 evaluable patient .</brief_summary>
	<brief_title>Efficacy Tolerability Study Treat Mild Moderate Anxiety</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Patients achieve score 18 29 point Hamilton Scale Anxiety ; Individuals ethnic group male female , age 18 year ; Consent subject research ( consent form sign ) . Patients know hypersensitivity component formula ; Pregnant woman nurse mother ; Patients endogenous depression , schizophrenia , suicidal tendency ; Patients heart disease unabated , unabated kidney , liver lung unabated unabated , discretion investigator ; Addiction drug , include alcohol , discretion investigator ; Patients use medication could interfere effect drug study ; Impossibility compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Passiflora , Crataegus Salix</keyword>
	<keyword>Mild Moderate anxiety</keyword>
	<keyword>Tablet</keyword>
	<keyword>To evaluate efficacy tolerability combination</keyword>
</DOC>